Back to Market Feed

DASATINIB 100 MG TABLET

DASATINIB
$27.9731per EA

Strength

100 mg/1

NDC

59651054630

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

DASATINIB

Approval Type

Generic (ANDA)

FDA Application

ANDA216547

On Market Since

4/22/2025

Pharmacological Classes

Cytochrome P450 3A4 Inhibitors
Kinase Inhibitor
Protein Kinase Inhibitors

Price History

1W

0.0%

1M

-4.2%

3M

-6.8%

6M

-85.4%

1Y

N/A

3Y

N/A

5Y

N/A

All

-85.4%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

DILTIAZEM 30 MG TABLET
Generic
00093031801•Teva Pharmaceuticals USA Inc.
$0.0523
per EA
DILTIAZEM 30 MG TABLET
Generic
00093031805•Teva Pharmaceuticals USA Inc.
$0.0523
per EA
DILTIAZEM 30 MG TABLET
Generic
50228048101•ScieGen Pharmaceuticals Inc.
$0.0523
per EA
DILTIAZEM 30 MG TABLET
Generic
50228048105•ScieGen Pharmaceuticals Inc.
$0.0523
per EA
DILTIAZEM 30 MG TABLET
Generic
60687071701•American Health Packaging
$0.0523
per EA
DILTIAZEM 60 MG TABLET
Generic
00093031901•Teva Pharmaceuticals USA Inc.
$0.0667
per EA
DILTIAZEM 60 MG TABLET
Generic
00093031905•Teva Pharmaceuticals USA Inc.
$0.0667
per EA
DILTIAZEM 60 MG TABLET
Generic
50228048201•ScieGen Pharmaceuticals Inc.
$0.0667
per EA
DILTIAZEM 60 MG TABLET
Generic
50228048205•ScieGen Pharmaceuticals Inc.
$0.0667
per EA
DILTIAZEM 60 MG TABLET
Generic
60687072801•American Health Packaging
$0.0667
per EA